503162 — Reliance Chemotex Industries Income Statement
0.000.00%
- IN₹1.38bn
- IN₹3.82bn
- IN₹3.59bn
- 30
- 36
- 41
- 25
Annual income statement for Reliance Chemotex Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,556 | 3,618 | 3,649 | 3,672 | 3,586 |
Cost of Revenue | |||||
Gross Profit | 945 | 1,440 | 1,322 | 1,284 | 1,844 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,399 | 3,211 | 3,396 | 3,461 | 3,410 |
Operating Profit | 157 | 406 | 253 | 211 | 176 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 104 | 274 | 167 | 56.3 | 36.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 69.3 | 181 | 124 | 32.1 | 40.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 69.3 | 181 | 124 | 32.1 | 40.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 69.3 | 181 | 124 | 32.1 | 40.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 9.32 | 24.6 | 16.9 | 4.25 | 5.36 |
Dividends per Share |